0002-6145 : Baqsimi 3 mg Nasal Powder
NDC: | 0002-6145 |
Labeler: | Eli Lilly and Company |
Product Type: | Human Prescription Drug |
Drug Name: | Baqsimi |
Dosage Form: | Nasal Powder |
Application #: | NDA210134 |
Rev. Date: |
NDC Package Codes:
- 0002-6145-11: 1 TUBE IN 1 CARTON (0002‑6145‑11) > 1 BOTTLE, UNIT‑DOSE IN 1 TUBE (0002‑6145‑02) > 1 POWDER IN 1 BOTTLE, UNIT‑DOSE (0002‑6145‑01)
- 0002-6145-27: 2 TUBE IN 1 CARTON (0002‑6145‑27) > 1 BOTTLE, UNIT‑DOSE IN 1 TUBE (0002‑6145‑02) > 1 POWDER IN 1 BOTTLE, UNIT‑DOSE (0002‑6145‑01)
Active Ingredients:
- Glucagon
Dosage Strength:
- 3 mg
Pharmaceutical Classes:
- Antihypoglycemic Agent [EPC]
- Gastrointestinal Motility Inhibitor [EPC]
- Increased Gluconeogenesis [PE]
- Increased Glycogenolysis [PE]
- Decreased GI Smooth Muscle Tone [PE]
- Decreased GI Motility [PE]
- Decreased Glycolysis [PE]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0002-5802Next: 0002-6216 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.